Is Thymalin FDA approved?
No. This profile records Thymalin as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE LONGEVITY PEPTIDE
A-6 Thymic Peptide Extract
Thymalin is one of the most studied thymic peptides, developed by Dr. Khavinson in Russia. It enhances T-cell production and balances immune responses. Long-term human trials reported increased lifespan. It works through epigenetic mechanisms to reactivate genes silenced by aging.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Thymalin as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 5 mg subcutaneously daily for 10 days.
Schedule: daily. Cycle: 10 days on, 12 weeks off (repeat 2-3x yearly). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Upregulates IL-7 receptor, FOXN1, and Notch1
Modifies histone acetylation and DNA methylation
Reactivates hTERT for telomere maintenance
Activates HO-1, NQO1 antioxidant genes
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.